Article Text

Download PDFPDF

Original article
Recessive germline SDHA and SDHB mutations causing leukodystrophy and isolated mitochondrial complex II deficiency
  1. Charlotte L Alston1,
  2. James E Davison2,3,
  3. Francesca Meloni4,
  4. Francois H van der Westhuizen1,5,
  5. Langping He1,
  6. Hue-Tran Hornig-Do1,
  7. Andrew C Peet2,6,
  8. Paul Gissen7,8,
  9. Paola Goffrini4,
  10. Ileana Ferrero4,
  11. Evangeline Wassmer2,
  12. Robert McFarland1,
  13. Robert W Taylor1
  1. 1Wellcome Trust Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK
  2. 2Birmingham Children's Hospital, Birmingham, UK
  3. 3School of Clinical & Experimental Medicine, University of Birmingham, Birmingham, UK
  4. 4Department of Genetics, Biology of Microorganisms, Anthropology and Evolution, University of Parma, Parma, Italy
  5. 5Centre for Human Metabonomics, North-West University, Potchefstroom, South Africa
  6. 6Cancer Sciences, University of Birmingham, Birmingham, UK
  7. 7UCL Institute of Child Health, London, UK
  8. 8Great Ormond Street Hospital for Children NHS Trust, London, UK
  1. Correspondence to Professor Robert W Taylor, Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; robert.taylor{at}ncl.ac.uk

Abstract

Background Isolated complex II deficiency is a rare form of mitochondrial disease, accounting for approximately 2% of all respiratory chain deficiency diagnoses. The succinate dehydrogenase (SDH) genes (SDHA, SDHB, SDHC and SDHD) are autosomally-encoded and transcribe the conjugated heterotetramers of complex II via the action of two known assembly factors (SDHAF1 and SDHAF2). Only a handful of reports describe inherited SDH gene defects as a cause of paediatric mitochondrial disease, involving either SDHA (Leigh syndrome, cardiomyopathy) or SDHAF1 (infantile leukoencephalopathy). However, all four SDH genes, together with SDHAF2, have known tumour suppressor functions, with numerous germline and somatic mutations reported in association with hereditary cancer syndromes, including paraganglioma and pheochromocytoma.

Methods and results Here, we report the clinical and molecular investigations of two patients with histochemical and biochemical evidence of a severe, isolated complex II deficiency due to novel SDH gene mutations; the first patient presented with cardiomyopathy and leukodystrophy due to compound heterozygous p.Thr508Ile and p.Ser509Leu SDHA mutations, while the second patient presented with hypotonia and leukodystrophy with elevated brain succinate demonstrated by MR spectroscopy due to a novel, homozygous p.Asp48Val SDHB mutation. Western blotting and BN-PAGE studies confirmed decreased steady-state levels of the relevant SDH subunits and impairment of complex II assembly. Evidence from yeast complementation studies provided additional support for pathogenicity of the SDHB mutation.

Conclusions Our report represents the first example of SDHB mutation as a cause of inherited mitochondrial respiratory chain disease and extends the SDHA mutation spectrum in patients with isolated complex II deficiency.

  • Neurology
  • Mitochondrial disease
  • Genetic screening/counselling

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.